Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
The combination of monthly dosing, a new indication category (neuroscience instead of cardiometabolic), and the broader GLP-1-and-addiction signal is the most interesting pipeline development in this class right now
Ankarfeldt MZ, Thorsted BL, Groenwold RH, Adalsteinsson E, Ali MS, Klungel OH
This benefit is seen in individuals with and without diabetes, particularly those with a history of cardiovascular disease
doi: 10.1073/pnas.2025094118 15 Bar EyalL.Ranjbar ChoubehR.CohenE.EisenbergI.TamburuC.DorogiM.et al
Peripheral nerve sheath tumors: an electron microscopic study of 43 cases
US$ 24.23
US$ 21.72
US$ 26.62
US$ 25.55
US$ 20.18
US$ 28.92
US$ 26.84
US$ 23.51
